. Author manuscript; available in PMC: 2019 Oct 1.

Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Apr 18;156(4):1543–1549.e4. doi: 10.1016/j.jtcvs.2018.03.169

Table 4.

Risk-adjusted association between POAF and short-term outcomes

	Odds Ratio	95% CI	p-value	C-statistic
Operative mortality	0.98	(0.51-1.87)	0.944	0.685
Major morbidity^†	2.46	(1.49-4.06)	0.0004	0.667
Permanent stroke	1.19	(0.42-3.40)	0.747	0.714
Unplanned RVAD	2.90	(1.30-6.49)	0.010	0.720
Renal failure	1.96	(0.97-3.97)	0.060	0.740
Cardiac Arrest	3.42	(1.21-9.71)	0.021	0.713
Prolonged ventilation	2.68	(1.64-4.37)	<0.0001	0.662
Reoperation	1.87	(1.10-3.18)	0.020	0.659
Discharge to facility	2.23	(1.25-4.01)	0.007	0.733

	Estimate	95% CI	p-value	R²

Intensive Care Unit LOS (hrs)	87.7	(22.5-153.0)	0.009	0.124
Postoperative LOS (days)	4.9	(0.7-9.2)	0.022	0.091
Intensive care unit cost	$5,488	(-2539-13,515)	0.180	0.184
Total hospital cost	$19,183	(−16,918-55,283)	0.297	0.099

LOS= length of stay; POAF = postoperative atrial fibrillation; RVAD = right ventricular assist device